pharmaobservatory 0.1.7 → 0.1.8

This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
Files changed (117) hide show
  1. checksums.yaml +4 -4
  2. data/README.md +83 -4
  3. data/docs/BiomarkerAlleleFrequenciesResponse.md +58 -0
  4. data/docs/BiomarkerAlleleFrequenciesRow.md +62 -0
  5. data/docs/BiomarkerAssayProvidersResponse.md +58 -0
  6. data/docs/BiomarkerAssayProvidersRow.md +72 -0
  7. data/docs/BiomarkerEvidenceByYearResponse.md +58 -0
  8. data/docs/BiomarkerEvidenceByYearRow.md +32 -0
  9. data/docs/BiomarkerTraversalStatusResponse.md +58 -0
  10. data/docs/BiomarkerTraversalStatusRow.md +36 -0
  11. data/docs/BiomarkersApi.md +320 -0
  12. data/docs/CompaniesApi.md +1001 -99
  13. data/docs/CompanyAssetsRow.md +5 -1
  14. data/docs/CompanyBiomarkerCapabilityResponse.md +58 -0
  15. data/docs/CompanyBiomarkerCapabilityRow.md +68 -0
  16. data/docs/CompanyProgramsRow.md +5 -1
  17. data/docs/CompanyRareDiseaseDeclarationsResponse.md +58 -0
  18. data/docs/CompanyRareDiseaseDeclarationsRow.md +52 -0
  19. data/docs/GxpFacilitiesRow.md +22 -0
  20. data/docs/LegalEntitiesApi.md +981 -101
  21. data/docs/LegalEntitiesRecordAttributes.md +6 -0
  22. data/docs/LegalEntitySecFilingsResponse.md +58 -0
  23. data/docs/LegalEntitySecFilingsRow.md +44 -0
  24. data/docs/OrgDisclosureTrendResponse.md +58 -0
  25. data/docs/OrgDisclosureTrendRow.md +62 -0
  26. data/docs/OwnershipSourceCoverageResponse.md +58 -0
  27. data/docs/OwnershipSourceCoverageRow.md +62 -0
  28. data/docs/ProgramLicensingCandidatesRow.md +5 -1
  29. data/docs/ProgramsRow.md +1 -1
  30. data/docs/RwdConductorDeliveryResponse.md +58 -0
  31. data/docs/RwdConductorDeliveryRow.md +74 -0
  32. data/docs/RwdConductorFootprintResponse.md +58 -0
  33. data/docs/RwdConductorFootprintRow.md +40 -0
  34. data/docs/RwdConductorStudiesResponse.md +58 -0
  35. data/docs/RwdConductorStudiesRow.md +42 -0
  36. data/docs/RwdConductorsApi.md +393 -0
  37. data/docs/RwdConductorsRecord.md +38 -0
  38. data/docs/RwdConductorsResponse.md +58 -0
  39. data/docs/RwdConductorsRow.md +72 -0
  40. data/docs/RwdInstitutionsApi.md +153 -0
  41. data/docs/RwdInstitutionsRecord.md +38 -0
  42. data/docs/RwdInstitutionsResponse.md +58 -0
  43. data/docs/RwdInstitutionsRow.md +154 -0
  44. data/docs/RwdNetworksApi.md +153 -0
  45. data/docs/RwdNetworksRecord.md +38 -0
  46. data/docs/RwdNetworksResponse.md +58 -0
  47. data/docs/RwdNetworksRow.md +110 -0
  48. data/docs/RwdStudiesApi.md +80 -0
  49. data/docs/SbtiCrosscheckResponse.md +58 -0
  50. data/docs/SbtiCrosscheckRow.md +48 -0
  51. data/docs/SponsorDeliveryResponse.md +58 -0
  52. data/docs/SponsorDeliveryRow.md +52 -0
  53. data/docs/SponsorPatentMentionsResponse.md +58 -0
  54. data/docs/SponsorPatentMentionsRow.md +42 -0
  55. data/docs/SponsorTrialConditionsResponse.md +58 -0
  56. data/docs/SponsorTrialConditionsRow.md +36 -0
  57. data/docs/SponsorTrialDrugsResponse.md +58 -0
  58. data/docs/SponsorTrialDrugsRow.md +34 -0
  59. data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
  60. data/lib/pharmaobservatory/api/companies_api.rb +1131 -130
  61. data/lib/pharmaobservatory/api/legal_entities_api.rb +1047 -123
  62. data/lib/pharmaobservatory/api/rwd_conductors_api.rb +413 -0
  63. data/lib/pharmaobservatory/api/rwd_institutions_api.rb +161 -0
  64. data/lib/pharmaobservatory/api/rwd_networks_api.rb +161 -0
  65. data/lib/pharmaobservatory/api/rwd_studies_api.rb +84 -0
  66. data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +478 -0
  67. data/lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb +465 -0
  68. data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +478 -0
  69. data/lib/pharmaobservatory/models/biomarker_assay_providers_row.rb +520 -0
  70. data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +478 -0
  71. data/lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb +300 -0
  72. data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +478 -0
  73. data/lib/pharmaobservatory/models/biomarker_traversal_status_row.rb +322 -0
  74. data/lib/pharmaobservatory/models/company_assets_row.rb +24 -2
  75. data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +478 -0
  76. data/lib/pharmaobservatory/models/company_biomarker_capability_row.rb +498 -0
  77. data/lib/pharmaobservatory/models/company_programs_row.rb +24 -2
  78. data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +478 -0
  79. data/lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb +410 -0
  80. data/lib/pharmaobservatory/models/gxp_facilities_row.rb +122 -1
  81. data/lib/pharmaobservatory/models/legal_entities_record_attributes.rb +28 -1
  82. data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +478 -0
  83. data/lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb +370 -0
  84. data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +478 -0
  85. data/lib/pharmaobservatory/models/org_disclosure_trend_row.rb +465 -0
  86. data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +478 -0
  87. data/lib/pharmaobservatory/models/ownership_source_coverage_row.rb +465 -0
  88. data/lib/pharmaobservatory/models/program_licensing_candidates_row.rb +24 -2
  89. data/lib/pharmaobservatory/models/programs_row.rb +1 -1
  90. data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +478 -0
  91. data/lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb +537 -0
  92. data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +478 -0
  93. data/lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb +346 -0
  94. data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +478 -0
  95. data/lib/pharmaobservatory/models/rwd_conductor_studies_row.rb +355 -0
  96. data/lib/pharmaobservatory/models/rwd_conductors_record.rb +385 -0
  97. data/lib/pharmaobservatory/models/rwd_conductors_response.rb +478 -0
  98. data/lib/pharmaobservatory/models/rwd_conductors_row.rb +526 -0
  99. data/lib/pharmaobservatory/models/rwd_institutions_record.rb +385 -0
  100. data/lib/pharmaobservatory/models/rwd_institutions_response.rb +478 -0
  101. data/lib/pharmaobservatory/models/rwd_institutions_row.rb +981 -0
  102. data/lib/pharmaobservatory/models/rwd_networks_record.rb +385 -0
  103. data/lib/pharmaobservatory/models/rwd_networks_response.rb +478 -0
  104. data/lib/pharmaobservatory/models/rwd_networks_row.rb +733 -0
  105. data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +478 -0
  106. data/lib/pharmaobservatory/models/sbti_crosscheck_row.rb +388 -0
  107. data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +478 -0
  108. data/lib/pharmaobservatory/models/sponsor_delivery_row.rb +410 -0
  109. data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +478 -0
  110. data/lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb +355 -0
  111. data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +478 -0
  112. data/lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb +322 -0
  113. data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +478 -0
  114. data/lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb +311 -0
  115. data/lib/pharmaobservatory/version.rb +1 -1
  116. data/lib/pharmaobservatory.rb +46 -0
  117. metadata +94 -2
@@ -12,7 +12,9 @@
12
12
  | **sponsor_group_name** | **String** | Display name of the sponsor's group. | [optional] |
13
13
  | **drug_id** | **String** | The drug key. | [optional] |
14
14
  | **drug_name** | **String** | The drug's name. | [optional] |
15
- | **max_phase** | **Integer** | Highest phase the sponsor reached on the drug: 0 early phase 1 through 6 for phase 4 (marketed); -1 when unstated. | [optional] |
15
+ | **max_phase** | **Integer** | Highest phase the sponsor reached on the drug on the 0 to 4 scale: 0 not reported, 1 through 4 for phase 1 through phase 4 (4 is marketed); a split phase folds up to its higher phase. | [optional] |
16
+ | **max_phase_label** | **String** | The furthest phase reached with the split phases kept: Early 1, Phase 1, Phase 1/2, Phase 2, Phase 2/3, Phase 3, Phase 4, or Not reported. max_phase is the same value folded onto 0 to 4 (a split phase counts as its higher phase). | [optional] |
17
+ | **max_phase_fine_rank** | **Integer** | The finest phase rank behind max_phase_label: 6 Phase 4, 5 Phase 3, 4 Phase 2/3, 3 Phase 2, 2 Phase 1/2, 1 Phase 1, 0 Early 1, -1 not reported. Sort on it to order programs by furthest phase with the split phases kept; max_phase is the same value folded onto 0 to 4. | [optional] |
16
18
  | **n_trials** | **Integer** | Distinct trials this sponsor leads on the drug. Counted once per trial within the sponsor organization, so it is not additive across a company's organizations. | [optional] |
17
19
  | **n_active** | **Integer** | Of those trials, the number recruiting, not yet recruiting, active or enrolling by invitation. | [optional] |
18
20
  | **last_year** | **Integer** | Latest start year among those trials. | [optional] |
@@ -33,6 +35,8 @@ instance = PharmaObservatory::CompanyAssetsRow.new(
33
35
  drug_id: null,
34
36
  drug_name: null,
35
37
  max_phase: null,
38
+ max_phase_label: null,
39
+ max_phase_fine_rank: null,
36
40
  n_trials: null,
37
41
  n_active: null,
38
42
  last_year: null,
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::CompanyBiomarkerCapabilityResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<CompanyBiomarkerCapabilityRow>**](CompanyBiomarkerCapabilityRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::CompanyBiomarkerCapabilityResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,68 @@
1
+ # PharmaObservatory::CompanyBiomarkerCapabilityRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **biomarker_validation_id** | **String** | The evidence assertion id. | [optional] |
8
+ | **organization_name** | **String** | The organization's name as filed on the evidence. | [optional] |
9
+ | **organization_org_id** | **String** | Legal-entity level: the organization record of the organization. | [optional] |
10
+ | **organization_company_id** | **String** | Company level: the company the organization belongs to (null when unresolved). | [optional] |
11
+ | **organization_company_name** | **String** | Display name of the organization's company. | [optional] |
12
+ | **organization_group_id** | **String** | Group level: the organization's current ultimate parent company; a root company's group is itself. | [optional] |
13
+ | **organization_group_name** | **String** | Display name of the organization's group. | [optional] |
14
+ | **gene_symbol** | **String** | The gene's HGNC (Human Genome Organisation Gene Nomenclature Committee) symbol; null for evidence that names no gene. | [optional] |
15
+ | **biomarker_id** | **String** | The biomarker's id (a hash, not the route key). | [optional] |
16
+ | **biomarker_display_name** | **String** | The biomarker's display name. | [optional] |
17
+ | **biomarker_kind** | **String** | The kind of biomarker. | [optional] |
18
+ | **biomarker_identity_status** | **String** | How firmly the biomarker's identity is resolved. | [optional] |
19
+ | **organization_role** | **String** | The organization's role in the evidence (for example assay developer or testing laboratory). | [optional] |
20
+ | **organization_match_tier** | **String** | How the organization was matched to its record. | [optional] |
21
+ | **tier** | **Integer** | The evidence tier, higher for stronger kinds of evidence. A label of the kind of evidence, not a quality score. | [optional] |
22
+ | **tier_label** | **String** | The evidence tier in words. | [optional] |
23
+ | **evidence_type** | **String** | The kind of evidence (companion diagnostic authorization, trial endpoint, trial eligibility, trial specimen collection, trial text mention or ClinVar clinical testing). | [optional] |
24
+ | **evidence_count** | **Integer** | Assertions that share this biomarker, organization and role. | [optional] |
25
+ | **evidence_ref** | **String** | The reference of the evidence (a trial id, a device application number or a project id). | [optional] |
26
+ | **evidence_ref_kind** | **String** | What evidence_ref is. | [optional] |
27
+ | **trial_id** | **String** | The trial's registry id (NCT, National Clinical Trial, number) when the evidence is a trial. | [optional] |
28
+ | **citation_url** | **String** | A link to the evidence. | [optional] |
29
+ | **evidence_snippet** | **String** | A short excerpt of the evidence. | [optional] |
30
+ | **biomarker_role** | **String** | The role the biomarker plays in the evidence. | [optional] |
31
+ | **is_surrogate_endpoint_claim** | **Boolean** | Whether the evidence claims the biomarker as a surrogate endpoint. | [optional] |
32
+ | **clinvar_scv_count** | **Integer** | ClinVar submissions behind a ClinVar row. | [optional] |
33
+
34
+ ## Example
35
+
36
+ ```ruby
37
+ require 'pharmaobservatory'
38
+
39
+ instance = PharmaObservatory::CompanyBiomarkerCapabilityRow.new(
40
+ biomarker_validation_id: null,
41
+ organization_name: null,
42
+ organization_org_id: null,
43
+ organization_company_id: null,
44
+ organization_company_name: null,
45
+ organization_group_id: null,
46
+ organization_group_name: null,
47
+ gene_symbol: null,
48
+ biomarker_id: null,
49
+ biomarker_display_name: null,
50
+ biomarker_kind: null,
51
+ biomarker_identity_status: null,
52
+ organization_role: null,
53
+ organization_match_tier: null,
54
+ tier: null,
55
+ tier_label: null,
56
+ evidence_type: null,
57
+ evidence_count: null,
58
+ evidence_ref: null,
59
+ evidence_ref_kind: null,
60
+ trial_id: null,
61
+ citation_url: null,
62
+ evidence_snippet: null,
63
+ biomarker_role: null,
64
+ is_surrogate_endpoint_claim: null,
65
+ clinvar_scv_count: null
66
+ )
67
+ ```
68
+
@@ -14,7 +14,9 @@
14
14
  | **drug_name** | **String** | The drug's name. | [optional] |
15
15
  | **condition_id** | **String** | The condition key, a MeSH (Medical Subject Headings) descriptor id (D followed by six to nine digits). | [optional] |
16
16
  | **condition_name** | **String** | The condition's name. | [optional] |
17
- | **max_phase** | **Integer** | Highest phase reached: 0 early phase 1 through 6 for phase 4 (marketed); -1 when unstated. | [optional] |
17
+ | **max_phase** | **Integer** | Highest phase reached on the 0 to 4 scale: 0 not reported, 1 through 4 for phase 1 through phase 4 (4 is marketed); a split phase folds up to its higher phase. | [optional] |
18
+ | **max_phase_label** | **String** | The furthest phase reached with the split phases kept: Early 1, Phase 1, Phase 1/2, Phase 2, Phase 2/3, Phase 3, Phase 4, or Not reported. max_phase is the same value folded onto 0 to 4 (a split phase counts as its higher phase). | [optional] |
19
+ | **max_phase_fine_rank** | **Integer** | The finest phase rank behind max_phase_label: 6 Phase 4, 5 Phase 3, 4 Phase 2/3, 3 Phase 2, 2 Phase 1/2, 1 Phase 1, 0 Early 1, -1 not reported. Sort on it to order programs by furthest phase with the split phases kept; max_phase is the same value folded onto 0 to 4. | [optional] |
18
20
  | **n_trials** | **Integer** | Lead-sponsored trials in the program. | [optional] |
19
21
  | **n_active** | **Integer** | Of those, trials in an active status. | [optional] |
20
22
  | **last_year** | **Integer** | Latest trial start year. | [optional] |
@@ -39,6 +41,8 @@ instance = PharmaObservatory::CompanyProgramsRow.new(
39
41
  condition_id: null,
40
42
  condition_name: null,
41
43
  max_phase: null,
44
+ max_phase_label: null,
45
+ max_phase_fine_rank: null,
42
46
  n_trials: null,
43
47
  n_active: null,
44
48
  last_year: null,
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::CompanyRareDiseaseDeclarationsResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<CompanyRareDiseaseDeclarationsRow>**](CompanyRareDiseaseDeclarationsRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::CompanyRareDiseaseDeclarationsResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,52 @@
1
+ # PharmaObservatory::CompanyRareDiseaseDeclarationsRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **assertion_id** | **String** | The declaration assertion id. | [optional] |
8
+ | **organization_name** | **String** | The organization's name as the source filed it. | [optional] |
9
+ | **organization_org_id** | **String** | Legal-entity level: the organization record of the organization. | [optional] |
10
+ | **organization_company_id** | **String** | Company level: the company the organization belongs to (null when unresolved). | [optional] |
11
+ | **organization_company_name** | **String** | Display name of the organization's company. | [optional] |
12
+ | **organization_group_id** | **String** | Group level: the organization's current ultimate parent company; a root company's group is itself. | [optional] |
13
+ | **organization_group_name** | **String** | Display name of the organization's group. | [optional] |
14
+ | **declared_function** | **String** | The function the source states for the organization. | [optional] |
15
+ | **evidence_type** | **String** | The kind of evidence the source gives. | [optional] |
16
+ | **authority_class** | **String** | How authoritative the source is for the claim. | [optional] |
17
+ | **source_key** | **String** | The source the assertion comes from. | [optional] |
18
+ | **source_record_id** | **String** | The source's own record id. | [optional] |
19
+ | **source_url** | **String** | A link to the source record. | [optional] |
20
+ | **observed_at** | **Time** | When the assertion was observed (UTC). | [optional] |
21
+ | **last_verified_at** | **Time** | When the assertion was last verified (UTC). | [optional] |
22
+ | **confidence** | **Float** | The source's or the extraction's own confidence; null when none is stated. | [optional] |
23
+ | **license_name** | **String** | The licence of the source. | [optional] |
24
+ | **attribution** | **String** | The credit line for the source. | [optional] |
25
+
26
+ ## Example
27
+
28
+ ```ruby
29
+ require 'pharmaobservatory'
30
+
31
+ instance = PharmaObservatory::CompanyRareDiseaseDeclarationsRow.new(
32
+ assertion_id: null,
33
+ organization_name: null,
34
+ organization_org_id: null,
35
+ organization_company_id: null,
36
+ organization_company_name: null,
37
+ organization_group_id: null,
38
+ organization_group_name: null,
39
+ declared_function: null,
40
+ evidence_type: null,
41
+ authority_class: null,
42
+ source_key: null,
43
+ source_record_id: null,
44
+ source_url: null,
45
+ observed_at: null,
46
+ last_verified_at: null,
47
+ confidence: null,
48
+ license_name: null,
49
+ attribution: null
50
+ )
51
+ ```
52
+
@@ -5,6 +5,8 @@
5
5
  | Name | Type | Description | Notes |
6
6
  | ---- | ---- | ----------- | ----- |
7
7
  | **facility_key** | **String** | The canonical facility id. | [optional] |
8
+ | **registry** | **String** | The registry of the lead member record. Provenance and a facet, never a join key. | [optional] |
9
+ | **registry_native_site_id** | **String** | The lead registry's own site id (FEI, EudraGMDP site key, Health Canada location id). | [optional] |
8
10
  | **registry_facility_keys** | **Array<String>** | The registry records the facility is made of, each as registry:native site id (for example fda_fei:3004123456), sorted. | [optional] |
9
11
  | **facility_name** | **String** | The facility's name. | [optional] |
10
12
  | **member_count** | **Integer** | How many registry records are clustered into the facility. | [optional] |
@@ -38,16 +40,25 @@
38
40
  | **org_regulators** | **Array<String>** | The regulators holding an organization-level record for the operating firm (this carries the UK MHRA leg). | [optional] |
39
41
  | **severity_rank** | **Integer** | The in-force site-scope severity, 0 (no signal) to 4 (non-compliant). | [optional] |
40
42
  | **severity_level** | **String** | The in-force site-scope severity: no_signal, clean, advisory, action or non_compliant. | [optional] |
43
+ | **severity_scope** | **String** | site when a site-scope verdict set the severity rank, none when nothing did. Never org. | [optional] |
41
44
  | **severity_source** | **String** | The regulator behind the severity: fda, ema, health_canada or mhra. | [optional] |
42
45
  | **severity_signal_type** | **String** | The kind of signal behind the severity (for example an inspection classification). | [optional] |
43
46
  | **severity_raw_verdict** | **String** | The regulator's own verdict behind the severity (for example OAI). | [optional] |
44
47
  | **severity_signal_date** | **Date** | The date of the signal behind the severity. | [optional] |
48
+ | **severity_source_url** | **String** | The source page of the signal that set the severity. | [optional] |
45
49
  | **worst_severity_rank_ever** | **Integer** | The highest site-scope severity the facility has ever had, 0 to 4. | [optional] |
46
50
  | **worst_severity_level_ever** | **String** | The worst severity ever: no_signal, clean, advisory, action or non_compliant. | [optional] |
51
+ | **worst_severity_raw_verdict** | **String** | The regulator's own verdict word behind the worst severity ever. | [optional] |
52
+ | **worst_severity_signal_date** | **Date** | The date of the signal behind the worst severity ever. | [optional] |
47
53
  | **has_quality_signal** | **Boolean** | True when the facility has any quality signal. | [optional] |
54
+ | **has_site_scope_signal** | **Boolean** | True when a signal is about this site itself. | [optional] |
55
+ | **has_org_scope_signal** | **Boolean** | True when a signal is about the operating firm. | [optional] |
48
56
  | **latest_signal_date** | **Date** | The date of the latest signal of any scope. | [optional] |
57
+ | **first_signal_date** | **Date** | The date of the earliest dated signal of any scope. | [optional] |
49
58
  | **n_signals_total** | **Integer** | Signals of any scope, all time. | [optional] |
50
59
  | **n_signals_365d** | **Integer** | Signals in the last 365 days of the build. | [optional] |
60
+ | **n_signals_1095d** | **Integer** | Signals in the last 1,095 days of the build. | [optional] |
61
+ | **n_signals_1825d** | **Integer** | Signals in the last 1,825 days of the build. | [optional] |
51
62
  | **n_inspections** | **Integer** | Inspections of the site by any regulator. | [optional] |
52
63
  | **latest_inspection_date** | **Date** | The date of the latest inspection by any regulator. | [optional] |
53
64
  | **n_fda_inspections** | **Integer** | FDA inspections of the site. | [optional] |
@@ -80,6 +91,8 @@ require 'pharmaobservatory'
80
91
 
81
92
  instance = PharmaObservatory::GxpFacilitiesRow.new(
82
93
  facility_key: null,
94
+ registry: null,
95
+ registry_native_site_id: null,
83
96
  registry_facility_keys: null,
84
97
  facility_name: null,
85
98
  member_count: null,
@@ -113,16 +126,25 @@ instance = PharmaObservatory::GxpFacilitiesRow.new(
113
126
  org_regulators: null,
114
127
  severity_rank: null,
115
128
  severity_level: null,
129
+ severity_scope: null,
116
130
  severity_source: null,
117
131
  severity_signal_type: null,
118
132
  severity_raw_verdict: null,
119
133
  severity_signal_date: null,
134
+ severity_source_url: null,
120
135
  worst_severity_rank_ever: null,
121
136
  worst_severity_level_ever: null,
137
+ worst_severity_raw_verdict: null,
138
+ worst_severity_signal_date: null,
122
139
  has_quality_signal: null,
140
+ has_site_scope_signal: null,
141
+ has_org_scope_signal: null,
123
142
  latest_signal_date: null,
143
+ first_signal_date: null,
124
144
  n_signals_total: null,
125
145
  n_signals_365d: null,
146
+ n_signals_1095d: null,
147
+ n_signals_1825d: null,
126
148
  n_inspections: null,
127
149
  latest_inspection_date: null,
128
150
  n_fda_inspections: null,